News from the healthcare data industry
Experts from the health information specialist explain how the use of RWD and RWE has helped speed up and improve the development of therapies and vaccines. Source: https://www.outsourcing-pharma.com/Article/2022/09/12/real-world-evidence-helps-accelerate-research-wolters-kluwer-health?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright
Despite substantial progress made in cancer research to date, there is much about the disease that remains a mystery. The facts are in the figures. In 2020 alone, 1.3 million...
To facilitate FDA’s internal tracking of submissions to the Agency that include real-world data (RWD) and real-world evidence (RWE), this guidance encourages sponsors and applicants to identify in their submission...
The use of real-world data (RWD) to help design clinical trials is nothing new but increasingly it is being used early in the process to boost trial diversity and inclusion....
Executive summary The proposed European Health Data Space (EHDS) is not a mere regulation, it is a vision for the future of health and care for Europe. More effective use...
Research will advance data movement and analysis, as well as develop tools for automating workflows to aid in decision support. 31-Aug-2022 1:25 PM EDT, by Department of Energy, Office of Science favorite_border...
Abstract Studies that generate real-world evidence on the effects of medical products through analysis of digital data collected in clinical practice provide key insights for regulators, payers, and other healthcare...
Please join the American Association for Cancer Research (AACR) for a briefing on Wednesday, September 21 (12 p.m. – 1:30 p.m. ET) at the National Press Club in Washington, D.C....
Executive Summary While real world data is reliable, synchronization challenges limit its use, Sanjay Vyas, executive vice president and managing director Parexel India tells Scrip in a wide-ranging interview that touches on aspects...
Abstract Individual organizations, such as hospitals, pharmaceutical companies, and health insurance providers, are currently limited in their ability to collect data that are fully representative of a disease population. This...